Evidence map›Paper›PMID 27060368›Full record

ArticleProteomics2016

Next-generation technologies for spatial proteomics: Integrating ultra-high speed MALDI-TOF and high mass resolution MALDI FTICR imaging mass spectrometry for protein analysis.

Jeffrey M Spraggins, David G Rizzo, Jessica L Moore, Michael J Noto, Eric P Skaar, Richard M Caprioli

Open access · greenAbstract read
In one paragraph

Article in Proteomics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed
15.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 163 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. MALDI spatial proteomics: a mini review of approaches and techniques.Analytical methods : advancing methods and applications · 2026
    Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Prospective on Imaging Mass Spectrometry in Clinical Diagnostics.Molecular & cellular proteomics : MCP · 2023
    Review
  19. Article
  20. Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jeffrey M SpragginsDepartment of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN, USA.
David G RizzoMass Spectrometry Research Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Jessica L MooreMass Spectrometry Research Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Michael J NotoDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Eric P SkaarDepartment of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN, USA.
Richard M CaprioliDepartment of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN, USA.
Vanderbilt University · USVanderbilt University Medical Center · USVA Tennessee Valley Healthcare System · US

Funding

Training (pp 214-245)P41GM103391 · NIGMS · VANDERBILT UNIVERSITY · PI NORRIS, JEREMY L · 2012 to 2020
$17.7M
Host-mediated zinc sequestration during Acinetobacter baumannii infectionR01AI101171 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WALTER J. CHAZIN, DAVID P. GIEDROC · 2013 to 2026
$8.2M
MOLECULAR BIOPHYSICS TRAINING PROGRAM AT VANDERBILTT32GM008320 · NIGMS · VANDERBILT UNIVERSITY · PI CHAZIN, WALTER J. · 1989 to 2023
$7.9M
Clinical and Translational Training Program in Pulmonary MedicineT32HL087738 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Lorraine B Ware · 2007 to 2026
$7.0M
Chemistry-Biology Interface Training GrantT32GM065086 · NIGMS · VANDERBILT UNIVERSITY · PI BACHMANN, BRIAN O, SULIKOWSKI, GARY ALLEN · 2002 to 2022
$7.0M
Spatial Analysis of Molecules in Tissue using MALDI-MSR01GM058008 · NIGMS · VANDERBILT UNIVERSITY · PI CAPRIOLI, RICHARD M · 1998 to 2015
$5.8M
15 Tesla Bruker SolariX FT-ICR mass spectrometerS10OD012359 · OD · VANDERBILT UNIVERSITY · PI CAPRIOLI, RICHARD M · 2012 to 2012
$1.6M
Imaging the struggle for nutrient metal between host and pathogenR21AI107233 · NIAID · VANDERBILT UNIVERSITY · PI SKAAR, ERIC P · 2013 to 2014
$415k
Immunotherapeutics for the treatment of Acinetobacter baumannii infectionI01BX002482 · VA · VETERANS HEALTH ADMINISTRATION · PI SKAAR, ERIC P · 2015 to 2017
–
BLRD VA I01 BX002482NHLBI NIH HHS T32 HL087738NIAID NIH HHS R01 AI101171NIAID NIH HHS R21 AI107233NIGMS NIH HHS P41 GM103391NIGMS NIH HHS R01 GM058008NIGMS NIH HHS T32 GM008320NIGMS NIH HHS T32 GM065086NIH HHS S10 OD012359
6 · The paper itself

Abstract

MALDI imaging mass spectrometry is a powerful analytical tool enabling the visualization of biomolecules in tissue. However, there are unique challenges associated with protein imaging experiments including the need for higher spatial resolution capabilities, improved image acquisition rates, and better molecular specificity. Here we demonstrate the capabilities of ultra-high speed MALDI-TOF and high mass resolution MALDI FTICR IMS platforms as they relate to these challenges. High spatial resolution MALDI-TOF protein images of rat brain tissue and cystic fibrosis lung tissue were acquired at image acquisition rates >25 pixels/s. Structures as small as 50 μm were spatially resolved and proteins associated with host immune response were observed in cystic fibrosis lung tissue. Ultra-high speed MALDI-TOF enables unique applications including megapixel molecular imaging as demonstrated for lipid analysis of cystic fibrosis lung tissue. Additionally, imaging experiments using MALDI FTICR IMS were shown to produce data with high mass accuracy (<5 ppm) and resolving power (∼75 000 at m/z 5000) for proteins up to ∼20 kDa. Analysis of clear cell renal cell carcinoma using MALDI FTICR IMS identified specific proteins localized to healthy tissue regions, within the tumor, and also in areas of increased vascularization around the tumor.

Indexed as

AnimalsBrainLipidsMolecular ImagingProteinsProteomicsRatsSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationLipidsProteinsCystic fibrosisFTICR MSHigh-throughputHuman clear cell renal cell carcinomaNutritional immunityTechnology

Identifiers

PMID27060368
PMCPMC5117945
OpenAlexW2318940845

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.